Omeros Corp. (3O8)
XSTU
Real-time Data
06:00 AM
Day's Range
15.2552 wk Range
3.35Overview - 3O8 - Omeros Corp.
Key Statistics
Valuation
Enterprise Value
229.48M
P/E (Trailing)
‪-322.99‬
PEG Ratio
‪1.37‬
Price / Book
‪-18.33‬
EV / EBITDA
‪-0.96‬
Profitability
Gross Margin
‪94.06%‬
Return on Assets
‪-1.02%‬
Return on Equity
‪2.76%‬
Ownership
Shares Outstanding
71.99M
Price stats
50-Day Avg
‪10.96‬
200-Day Avg
‪10.21‬
Peers - 3O8 - Omeros Corp.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 3O8XSTUOmeros Corp.+77.40%52-week change-323.00P/E (Trailing)—Profit Margin
- 37TXSTUForte Biosciences, Inc.+86.11%52-week change-13.91P/E (Trailing)—Profit Margin
- 0QFXSTUModerna Inc.+83.17%52-week change-18.38P/E (Trailing)‪54.83%‬Profit Margin
- 3920XSTUSpyre Therapeutics, Inc.+81.45%52-week change-38.38P/E (Trailing)—Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.18%52-week change-84.15P/E (Trailing)‪50.72%‬Profit Margin
- 5NRXSTUNanobiotix S.A.+78.42%52-week change—P/E (Trailing)—Profit Margin
- 2LBXSTUIovance Biotherapeutics Inc.+71.95%52-week change-6.33P/E (Trailing)‪34.27%‬Profit Margin
Profile Summary - 3O8 - Omeros Corp.
About
Omeros Corp. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company concentrates on immunologic and complement-mediated diseases, along with selected orphan and rare indications affecting inflammation, coagulopathies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
